Jung Kwan Jang (KGC) said on the 26th that it held an academic seminar on the theme of "latest efficacy research on red ginseng" at the International Congress on Natural Products Sciences (ICSB) recently held in Mississippi.
According to KGC that day, about 400 people, including officials from major institutions such as the U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH), as well as global researchers, attended the event.
According to research presented at the conference, red ginseng showed significant effects in various areas, including neuroprotection and anti-aging, blood sugar control, and quality-of-life improvement. In particular, it was reported that ginsenosides, the main components of red ginseng, cross the blood-brain barrier and contribute to neuroprotection.
Results also appeared in blood sugar-related clinical studies. In a domestic study, the red ginseng intake group showed significant reductions in both postprandial and fasting blood glucose, and improvements were confirmed in key indicators such as insulin secretion. KGC said this is evaluated as a factor that can strengthen competitiveness in the "metabolic health management" category, which has high demand in the global market.
KGC said large-scale human trials also demonstrated reduced oxidative stress and improved sleep quality.
Red ginseng products are currently expanding consumer touchpoints by entering major distribution channels such as Amazon, Costco, and Sprouts in the United States. In particular, KGC expected strong growth potential in the North American market because the ingredient aligns with global health trends such as gluten-free and caffeine-free.
A KGC official said, "Red ginseng is an ingredient with scientific evidence accumulated through more than 1,200 research papers," adding, "With this academic conference as a turning point, we plan to steadily increase market share by boosting global consumer trust and expanding locally tailored products."